Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC
Largest series shows marker sensitive, highly specific
New combination overcomes resistance
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy